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Health spendingA growing number of healthcare policy initiatives around the world have focused on the continuum of
care amongst the elderly, calling for renewed investments in integrated care to promote healthy aging
and to reduce health system costs. The study objective was to examine healthcare costs and cost drivers
for myocardial infarction (AMI) among Canadian Seniors across the care continuum from 2004 to 2012 in
Ontario, Canada. Cost estimates represented direct community and hospital-based costs including
physician services, diagnostic-testing, pharmaceuticals and hospitalizations obtained from Canadian
healthcare data sources. Separate costs were calculated for pre-state care, the hospital event, and post-
state care over a 6 year care continuum. Socio-demographic and co-morbid cost drivers were studied
using negative binomial regression in a cohort of 16,450 ﬁrst-time AMI seniors.
The average cost per patient across a six-year care continuum was $28,169 in 2008 constant Canadian
dollars. Almost three-quarters of these costs were derived from the event phase ($20,794), while
pre-state and post-state costs made up 12% and 14%, respectively ($3400 and $3974). Pre-state costs
per patient day were half of post-state costs ($3.11 versus $6.32 per day) when adjusted for survival.
Socio-demographic characteristics including age, gender and patient’s urban/rural residence, and co-
morbid illnesses were key cost drivers across the phases of care. This study provides a person-centered
health system perspective in the economic burden of AMI in Canada’s elderly and will inform health
policy related to integrated care strategies for heart disease in seniors.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Acute Myocardial Infarction (AMI) exacts a signiﬁcant burden of
illness world-wide. AMI is responsible for between 40% and 50% of
the 17 million annual cardiovascular disease deaths globally (Yusuf
et al., 2001; WHO, 2011), and represents the leading cause of mor-
bidity and mortality in North America (Tu et al., 1997). The impact
of AMI on the elderly is particularly profound, with a ten-fold
greater AMI incidence among those 65–74 as compared to those
35–44, and a persistently high case fatality rate for patients over
the age of 65 (Roger, 2007; Yazdanyar and Newman, 2009). Given
global trends in population aging and the anticipated increase in
corresponding AMI health care costs (Heidreneich et al., 2011;
Kim et al., 2013), governments around the world are growingincreasingly focused on integrated seniors strategies to address
heart disease across the continuum of care in order to promote
healthy aging and mitigate healthcare spending (Smith, 2009;
Health Council of Canada, 2012; Leatt et al., 2000; Nolte and
McKee, 2008).
The last decade has seen a growing interest in models of care for
AMI that promote coordination of services across the care contin-
uum, however there remains limited available evidence about
actual costs of AMI across the care trajectory (Nolte and McKee,
2008). Despite the substantive disease burden of AMI among the
elderly, AMI costing research across the care continuum is particu-
larly lacking for those over 65 (Tarride et al., 2009). In the Canadian
context, in which a single-payer universal healthcare provides
physician, hospital and drug coverage to all seniors, no study
has yet examined direct AMI costs in the elderly across the
complete continuum of care; exploring costs in community and
hospital-based care, both before and after the index AMI event.
This is surprising given that seniors have been shown to be among
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Krumholz et al., 1998) and that integrated care models for seniors
in general have been shown to improve health outcomes and cost-
savings overall (MacAdam, 2008; Carstairs and Keon, 2009).
The purpose of this study was to examine healthcare costs and
cost drivers for AMI among Canadian seniors across the care
continuum from 2004 to 2012 in Ontario, Canada. Patient cost data
are presented in aggregate but are also delineated in time across
the care trajectory to detail the costs of healthcare services prior
to AMI, the costs of acute in-patient AMI care, and the costs of
disease management following the AMI event. Finally, socio-
demographic and clinical factors that are major drivers of cost
along the patient’s care continuum are explored.
Methods
The Canadian Institute for Health Information’s Discharge
Abstract Database (DAD), housed at the Institute of Clinical Evalu-
ative Sciences (ICES) of Ontario, Canada was used to identify the
population-based study cohort. All patients between the ages of
65 and 105 who were admitted to Ontario hospitals with a most
responsible diagnosis of AMI (ICD-10 code (I21)) between April 1,
2007 and March 31, 2009 were included in the study. We
established incident AMI cases by selecting only those patients
for whom the absence of a hospitalization for AMI could be estab-
lished for up ﬁfteen years prior to the index AMI. Patients were
required to be residents of Ontario for the duration of the study
period to ensure that all services could be accurately tracked.
Patients living in the Kingston/Quinte/Rideau region were
excluded due to alternative billing arrangements in which services
could not be captured with available data sources.
For each patient, a trajectory was established to measure the
cost of key AMI-related services across a typical patient care
continuum. The methodology for developing and presenting cost
estimates was adapted from O’Brien et al. (2003) in which services
across the care trajectory were reported separately for the event
(hospitalizations associated with the patient’s AMI and one-year
follow-up heart-related readmissions) and for the post-state (com-
munity-based services following the AMI event). For the purposes
of this study, a third pre-state phase was introduced to account for
services associated with the patient’s care prior to the AMI event.
Cost estimates represented direct healthcare costs within the
community and hospital settings.
Longitudinal patient record
Longitudinal patient records were created using deterministic
linkage via unique encrypted patient health insurance numbers.
Ontario’s DAD was used to estimate the cost of in-patient services
associated with the AMI event, and all subsequent heart-related
readmissions (ICD-10 I codes) for up to one year following the
AMI index date. Patient records were linked with Ontario’s
Hospital Insurance Plan (OHIP) billing data to examine the costs
of relevant pre-state and post-state services for three years prior
to and three years following the AMI. This approach resulted in a
follow-up period of six years for each patient over a total study
period ranging between the ﬁscal years of 2004 and 2012.
Costing data sources and costing techniques
CIHI’s discharge abstract database
In-hospital patient costs were generated using a bottom-up
activity-based costing model to allocate costs for individual service
recipients based on service dates (Chapko et al., 2009; CIHI, 2011b).To estimate event costs, Resource Intensity Weights (RIW™)
within the DAD were used to determine the intensity of hospital
resource use for each patient based on the standard Canadian
patient case-mix classiﬁcation (Case Mix Groups, CMG™). CMGs
represent a standardized grouping of hospital services for a set of
major clinical categories, similar to the diagnosis-related grouping
(DRG) system used in the United States and in Europe (Hakkinen
et al., 2012; Feter et al., 1980). RIWs reﬂect the relative value of
hospital resources utilized for each inpatient case, including ﬁxed
and variable, direct and indirect costs attributable to inpatient care
(CIHI, 2011b). Indirect costs associated with transient cost centres
were allocated to cost centres using a reciprocal costing method –
simultaneous equality allocation method (SEAM) (CIHI, 2011b;
Young, 2003). Direct and indirect costs in each functional centre
were then assigned to the patient based on an algorithm that
accounted for unit costs and patient-speciﬁc workload (CIHI,
2011b). Canada’s activity-based costing methods, and RIW and
CMG standards have been documented elsewhere (CIHI, 2004,
2011b).
It should be noted that physician costs were not included in the
standard RIW costing methodology as physician payments are
handled outside of the hospital funding matrix in Canada. As such,
physician billing costs which are handled largely on a fee-for-
service basis in Ontario, Canada were directly allocated to relevant
hospitalization event costs using the admission and discharge
dates to develop complete event costs for each patient (Young,
2003). Individual RIWs for each discharge were multiplied against
the 2008 average cost per weighted case for Ontario hospitals, to
establish an in-hospital cost for each patient in the cohort (CIHI,
2013).
Ontario’s health insurance plan database (OHIP)
OHIP billing data was used to measure of the cost of laboratory
and diagnostic services and physician consultations associated
with the pre-state, event, and post-state phases of care based on
billing dates. Physician costs for targeted heart-related services
provided in the community were measured using a deﬁned set of
OHIP fee and diagnostic codes, adapted from Tu et al.’s (2001)
hospital-based methodology. Ontario’s 2008 Schedule of Beneﬁts
was used to assign costs to each billed physician service and
Ontario’s laboratory unit index was used to directly allocate costs
for laboratory services (OHIP, 1999).
Ontario’s drug beneﬁts database (ODB)
The Ontario Drug Program provides prescription drug coverage
for all Ontario residents aged 65 and over. ODB data were used to
measure the cost of medications within the pre-state and post-
state phases of care. Drug costs in the event phase were built into
the RIW hospital costing methodology and could not be isolated for
the purposes of comparison in this study. Cost estimates were
generated for all prescriptions ﬁlled in the community for the fol-
lowing therapeutic drug classes; Statins, Beta Blockers, Calcium
Channel Blockers and Ace-Inhibitors as per clinical practice guide-
lines (Tobe et al., 2011; Daskalopoulou et al., 2012; Anderson et al.,
2013). Costs for prescription drugs were generated by multiplying
the average cost per tablet by the quantity dispensed for each
claim and directly allocated to each patient in the pre-state and
post-state phases.
Demographic and clinical data sources
Clinical co-morbidity data were derived from CIHI’s DAD at the
time of AMI admission based on the Ontario Acute Myocardial
Mortality Prediction rules (Tu et al., 2001). Patient demographic
Table 1
Patient Characteristics.
Percentage (%) N
Socio-demographic characteristics
Average age at time of AMI event 79.7 16,450
Age range at time of AMI event 68–105 –
Age range for the full follow up period 65–103 –
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Patients’ urban/rural and socioeconomic status (SES) were deter-
mined using an area-based methodology in which the full patient
postal code was linked with the 2006 Census neighborhood data
(Statistics Canada). Patients were assigned a low, medium and high
SES based on median neighborhood income that mapped to the
Ontario income distribution.Male gender 51.9 8535
Low income (SES 1)b 44.4 7305
Medium income (SES 2)b 37.7 6200
High income (SES 3)b 17.9 2945
Median income 27,681 –
Patients in rural residence 14.4 2376
Co-morbiditiesa
Shock 3.5 573
Chronic heart failure 26.8 4415
Cancer 4.4 721
Cerebrovascular disease 3.7 612
Pulmonary edema 2.8 465
Acute renal failure 8.9 1459
Chronic renal failure 10.4 1696
Diabetes with complications 1.1 182
Cardiac dysrhythmias 20.1 3309
Abbreviations: AMI (acute myocardial infarction), SES (socioeconomic status).
a Co-morbid conditions based on Ontario AMI Mortality Prediction Rules, (Tu
et al., 2001).
b Area based income methodology based on income distribution in the 2006
Ontario Census data from Statistics Canada. Neighborhood income quintiles were
arranged such that the lowest two income groups formed the ‘low-income’ group,
the third and fourth quintiles formed the ‘middle-income’ group, and the ﬁfth
quintile formed the ‘high-income’ group.Statistical analysis
Patient costs in the pre-state, event and post-state phases were
calculated according to major spending categories. Cost per patient
day survived was calculated by dividing the total spending in each
phase of care by the total number of days contributed by each
patient based on individual survival. As with most econometric
data, cost distributions were heavily right-skewed, therefore both
average and median patient costs are presented. To address
non-normality, we used negative binomial regression to model
the independent effects of socio-demographic and clinical co-
morbidities on pre-state, event and post-state costs (Bond and
Farewell, 2009; Charkha et al., 2013). The over-dispersion parame-
ter alpha in each model was signiﬁcantly different from zero indi-
cating that the negative binomial was a better ﬁt to the data than
the Poisson (Agresti, 2001). To address the high volume of zeros in
pre and post-state costs, zero-inﬂated negative binomial regres-
sions were applied (Lewsey and Thompson, 2004). Socio-
demographic independent variables included age, sex, patient’s
urban/rural status and SES. Co-morbid independent variables
included congestive heart failure (CHF), cardiac dysrhythmias,
pulmonary edema, shock, chronic renal failure, acute renal failure,
diabetes with complications, malignancy, and cerebrovascular
disease (Tu et al., 2001). The regression models included an offset
to address differences in log survival following discharge from
hospital. Collinearity among predictor variables was determined
to be acceptable based on a variance inﬂation factor cut-off of
ten (Stevens, 1996). The Chi-Square Wald statistic was used to
determine the contribution of the main effects, and incident rate
ratios were used as the measure of association between groups.
The study was approved by the Ottawa Hospital Research Ethics
Board, Ottawa, Ontario, Canada.Results
Patient socio-demographic and co-morbid illness characteristics
A total of 16,450 Senior patients were included in the study
cohort, with an average age of 79.7 at the time of the index AMI
event. Patients’ ages ranged from 65 to 105 across the six-year con-
tinuum of care period. Fifty-two percent of the sample was male
and 14% lived in a rural area. The median personal income was
$27,681 dollars per annum. Among the co-morbid illnesses diag-
nosed at the time of AMI, CHF (27%) and cardiac dysrhythmia
(20%) were the two most common diagnoses (Table 1).
Crude and survival adjusted pre-state, event and post state costs
The crude average cost per patient for the six-year continuum of
care was $28,169 (Standard deviation (SD) 25,235) (Table 2). Of the
total cost across the care continuum, 74% ($20,794 (SD 24,221))
was associated with the in-patient event phase, 12% ($3400 (SD
2910)) with the pre-state phase and 14% ($3974 (SD 3397) with
the post-state phase in the community.
Table 3 delineates pre-state, event, and post-state cost per
patient day adjusted by survival over the six-year follow up period.
Once survival adjustments were applied, the cost per patient day ofpre-state care was less than half (49%) of post-state care in the
community ($3.11 (SD 2.65)) per day versus $6.32 (SD 14.39) per
day). The average event cost per patient day in hospital (based
on number of days in hospital) was $1759 (SD 1047).
Socio-demographic and clinical predictors of pre-state, event and post-
state costs
Table 4 presents results of the models examining socio-demo-
graphic and co-morbid illness predictors of pre-state, event, and
post-state costs adjusted by the offset survival variable.
Socio-demographic cost drivers
Across each of the three models, patient’s sex and location of
residence were signiﬁcant drivers of cost, when other factors were
controlled for. Being male increased expected pre-state cost by
6.1% (95% Conﬁdence Interval (CI) 1.03–1.09), event costs by
11.1%, (CI 1.08–1.14) and post-state costs by 4.6% (CI 1.02–1.08)
in comparison to female patients. Living in an urban area increased
patient’s expected pre-state cost by 12.9% (CI 1.08–1.18), event
costs by 5.9% (CI 1.02–1.09), and post-state costs by 11.8% (CI
1.08–1.16) compared to patient’s living in a rural area. Patient’s
age was a negative predictor of event cost and post-state cost,
decreasing expected costs by 0.7% (CI 0.991–0.995) and 3.6% (CI
0.966–0.970), respectively for each additional year. Patient’s SES
was not a signiﬁcant predictor of pre-state or post-state cost, when
all other factors were controlled for. However patient’s low SES
was a signiﬁcant predictor of in-hospital costs, increasing expected
event costs by 3.5% (CI 1.00–1.07) in comparison to patients with
high SES.
Co-morbid Illness cost drivers
All co-morbid illnesses included in our models were signiﬁcant
predictors of cost in at least one of the pre-state, event or post-state
Table 2
Crude average AMI patient pre and post- event, and state costs across the continuum of care (2008 constant Canadian Dollars).
Pre-state Hospitalization event Post-state Total
Pre-state costs (per patient
cost for the 3 years prior to
index AMI event)
Index AMI event costs index
hospitalization (in-hospital
drugs included in hospital cost)
One year follow-up
hospitalization event costs
(in-hospital drugs included
in hospital cost)
Post state costs (per patient
cost for the 3 years
following index AMI event)
Physician fees
Mean cost $ 1234.05 $1777.74 $365.81 $1707.31
(SD) (1554) (1785) (903) (2105)
Median cost $656.57 $1377.13 $0 $1008.36
(Inter-quartile range) (274–1606) (6427–14,628) (0–0) (129–2500)
Drugs
Mean cost $ 2166.45 NA NA $2266.83
(SD) (2020) (1913)
Median cost $ 1789.04 $2283.23
(Inter-quartile range) (282–3440) (249–3669)
Hospital
Mean cost NA $14,684.77 $3966.02 NA
(SD) (19,174) (12,868)
Median cost $9779.97 $0
(Inter-quartile range) (609–2157) (0–390)
Sub-total
Mean cost $3400.50 $16,462.21 $4331.83 $3974.14
(SD) (2910) (20,457) (13,382) (3397)
Median cost $2806.69 $10,656.24 $0 $3858.33
(Inter-quartile range) (1019–5041) (7365–16,520) (0–1325) (612–6091)
Total
% Total cost 12.07% 73.82% 14.11% $28,168.67
Mean cost $3400.50 $20,794.04 $3974.14 (25,235)
(SD) (2910) (24,221) (3397) $21,549.90
Median cost $2806.69 $13,454.72 $3858.33 (14,949–33,178)
(Inter-quartile range) (1019–5041) (8719–24,466) (612–6091)
Abbreviations: AMI (acute myocardial infarction), SD (standard deviation), NA (not available).
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tions grouped into two main types of cost drivers. One set of co-
morbid illnesses were signiﬁcant predictors of cost across the
entire care continuum. These co-morbid illnesses, including CHF,
diabetes with complications, shock, acute renal failure and cancers,
were positive predictors of cost in the pre-state and event phases
and then became negative predictors of cost in the post-state
phase. For example, presence of CHF was a signiﬁcant driver of
pre-state cost (increasing costs by 30.9% (CI 1.26–1.36)) and of
event costs (increasing costs by 60% (CI 1.56–1.64). Correspond-
ingly, presence of CHF decreased post-state costs by 5.5% (CI
0.91–0.98).
A second cost driver pattern was determined for cardiac
dysrhythmias, cerebrovascular disease and chronic renal failure.
These co-morbid illnesses were signiﬁcant predictors of cost in
the pre-state and event phases of care, but were not signiﬁcant
predictors of cost in the post-state event. For example, presence
of cardiac dysrhythmias increased expected pre-state costs by
12.6% (CI 1.08–1.17), and increased expected event costs by
30.6% (CI 1.27–1.35), but did not signiﬁcantly predict post-state
costs.Discussion
This study provided a ﬁrst-time population-based investigation
of community and hospital costs related to AMI across a six-year
care continuum for elderly patients in Ontario, Canada. The aver-
age healthcare cost per patient across the care continuum was
found to be $28,169 (SD 24,221) (2008 constant Canadian dollars).
Average in-patient AMI cost for the ﬁrst episode of care at $14,684
(SD 19,174) was within range of other acute care costing studies
conducted in the Unites States and Europe (Azoulay et al., 2003;Kauf et al., 2006; Tiemann, 2008; Hakkinen et al., 2012;
Krumholz et al., 1998). However this study’s novel approach to
AMI costing across the care continuum demonstrated the substan-
tial costs incurred beyond the acute care sector, by quantifying the
community-based healthcare costs at 26% of the total patient cost
across the six-year care continuum. This work further demon-
strated a twofold increase in community-based costs from pre-
state to post-state phases of care ($3.11 (pre-state) versus $6.32
(post-state) per patient day) when days survived were accounted
for. Taken together these results highlight the substantial eco-
nomic impact of AMI beyond the acute care sector and reinforce
the value of taking a health system perspective to view health
expenditures along a patient’s continuum of care.
Accurate and comprehensive cost data are critical in economic
evaluations in healthcare to assist decision makers in ensuring that
limited resources are allocated as efﬁciently as possible (Evans and
Crawford, 2000; Rice, 2000). Person-centric AMI cost estimates
which span the different phases of the care trajectory through time
are critical for the development of prevalence-based healthcare
spending estimates and comprehensive cost of illness studies that
may assist in future evaluation of care integration strategies for
Canada’s elderly (CDC, 2013; Rice and Miller, 1998). Person-centric
cost estimates can be useful for developing cost-effectiveness
studies in which net or incremental costs of care are considered
in relation to patient outcomes (Noyes and Holloway, 2004). The
cost estimates developed in this particular study which were based
on net (not incremental) costs may be used to develop average
cost-effectiveness ratios for non-competing choice cost analysis
to determine an intuitive cost per unit of health gained (Bang
and Zhao, 2012).
The novel care continuum costing approach used in this study
also identiﬁed key cost drivers at different phases of the care
trajectory and raised a number of important questions for future
Table 3
AMI community and hospital healthcare cost per patient day survived (2008 constant
Canadian Dollars).
Pre-state Hospitalization
event
Post-state
Primary care
cost for AMI
care per
patient day in
community
Hospitalization
events for AMI
care per patient
day in hospital
Primary care
cost for AMI
care per
patient day in
community
Mean cost per day $3.11 $1,758.58 $6.32
(SD) (2.65) (1047) (14.39)
Median cost per day $2.56 $1497.77 $4.67
Abbreviations: AMI (acute myocardial infarction), SD (standard deviation), NA
(not available).
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existing research in which the signiﬁcant role of clinical co-mor-
bidities in predicting AMI hospital costs has been demonstrated
(Krumholz et al., 1998; Evans et al., 2007; Smolderen et al.,
2010). By examining patient costs prior to the AMI event however,
this study also pointed to clinical co-morbidities as signiﬁcant cost
drivers in the pre-state phase. In particular, presence of CHF, acute
and chronic renal failure, and diabetes with complications had the
largest impact on expected pre-state costs and expected event
costs. These results may be indicative of continuity of care between
community and acute care, in which high treatment intensity for
patients with these conditions is occurring in both pre-state and
event phases of care. Given that these co-morbid conditions have
identiﬁable and modiﬁable risk factors that overlap with risk fac-
tors for AMI including obesity, hypertension, tobacco use, poor diet
and sedentary lifestyles (Yusuf et al., 2001; WHO, 2003), it is likely
that pre-state care is focused on addressing this common set of
precursive risk factors (Tobe et al., 2011). Further work exploring
the relationship between pre-state and event spending is
warranted to more fully elucidate the role of integrated care in
the prevention, treatment and management of AMI.
In pursuit of the continuum of care perspective for AMI, we also
examined cost-drivers in the post-event phase of care. In this
phase we found that a number of co-morbid illnesses were
signiﬁcant negative predictors of post-state costs. Speciﬁcally, the
presence of cancer, shock, acute renal failure, and CHF decreasedTable 4
Cost drivers of care for pre-state, event and post-state costs.
Pre-state Hos
RR 95%CI p-val RR
Socio-demographic characteristics
Age 1.000 ns ns 0.99
Sex (male) 1.061 1.027–1.095 0.0003 1.11
Urban patient residence 1.129 1.079–1.180 <.0001 1.05
SES low vs higha 1.026 ns ns 1.03
SES mid vs higha 1.029 ns ns 1.01
Co-morbid illnesses at time of AMI hospitalizationb
Shock 1.317 1.207–1.437 <.0001 1.35
Chronic heart failure 1.309 1.262–1.358 <.0001 1.60
Cancer 1.199 1.111–1.295 <.0001 1.11
Cerebrovascular disease 1.214 1.117–1.320 <.0001 1.38
Pulmonary edema 1.046 ns ns 1.18
Acute renal failure 1.198 1.132–1.269 <.0001 1.40
Chronic renal failure 1.446 1.372–1.525 <.0001 1.20
Diabetes with complications 1.528 1.317–1.774 <.0001 1.42
Cardiac dysrhythmias 1.126 1.082–1.171 <.0001 1.30
Abbreviations: AMI (acute myocardial infarction), SES (socioeconomic status), ns (not sig
a Area based income methodology based on income distribution in the 2006 Ontario
such that the lowest two income groups formed the ‘low-income’ group, the third and f
‘high-income’ group.
b Co-morbid conditions based on Ontario AMI mortality prediction rules, Tu et al., 20expected post-state costs. While these results may appear unintu-
itive, they likely point to an important relationship between
comorbid illness, survival and associated follow-up AMI costs that
requires further investigation. We propose that that these co-mor-
bid illnesses were negative cost-drivers of post-state cost because
of the high mortality rates associated with each condition (Tu et al.,
2001). Despite the fact that survival differences were accounted for
in the negative binomial model using a well-established offset
method (Bond and Farewell, 2009; Charkha et al., 2013), which
assumes a linear cost accumulation trajectory, costs have been
shown to accumulate over time as a non-linear step function
(Evans et al., 2007). If an AMI patient with acute renal failure died
one day following hospital discharge for example, the patient
would not have sufﬁcient time exposure to reach the next step
function in treatment and corresponding costs within the commu-
nity. In this scenario, acute renal failure would appear as a negative
cost-driver for follow up post-state AMI care. This work highlights
an important limitation within the existing literature and associ-
ated methods related to the time-varying non-linear nature of cost
and its association with mortality outcomes at the patient level
(Stargardt et al., 2013; McClellan et al., 1994; Schreyogg and
Stargardt, 2010). Future research that applies novel methods that
account for the time-varying nature of healthcare spending is
required to more fully elucidate the relationship between co-
morbid illness, mortality and the time-dependent nature of AMI
healthcare costs at the patient level across the care continuum.
Limitations
A number of limitations warrant consideration. First, the costs
presented here necessarily underestimate complete healthcare
costs in Canada for elderly AMI patients, as costs for home and long
term care were not included in the analysis. Instead this study esti-
mated costs based on available data for the three largest categories
of spending – hospitals, drugs and physicians (CIHI, 2004). Second,
the use of administrative healthcare data allowed only for an
examination of direct healthcare costs, rather than a summation
of direct and indirect costs associated with total burden of disease.
While indirect costs are useful for illustrating the impact of illness
on society, direct costs can be equally informative for healthcare
decision makers to illustrate opportunity costs for public health-
care resources utilized (Boccuzzi, 2003).pitalization event Post-state
95%CI p-val RR 95%CI p-val
3 0.991–0.995 <.0001 0.968 0.966–0.970 <.0001
1 1.085–1.138 <.0001 1.046 1.017–1.076 0.0017
9 1.025–1.095 0.0007 1.118 1.075–1.162 <.0001
5 1.002–1.070 0.0379 0.986 ns ns
9 ns ns 0.983 ns ns
6 1.271–1.446 <.0001 0.839 0.751–0.936 0.0017
0 1.557–1.645 <.0001 0.945 0.914–0.977 0.0008
9 1.057–1.185 0.0001 0.698 0.650–0.751 <.0001
7 1.304–1.475 <.0001 0.928 ns ns
1 1.099–1.269 <.0001 1.057 ns ns
9 1.350–1.470 <.0001 0.901 0.851–0.954 0.0004
4 1.157–1.252 <.0001 1.023 ns ns
6 1.275–1.596 <.0001 0.943 ns ns
6 1.268–1.345 <.0001 1.034 ns ns
niﬁcant), RR (incident rate ratio), 95%CI (95 percent conﬁdence interval).
Census data from Statistics Canada. Neighborhood income quintiles were arranged
ourth quintiles formed the ‘middle-income’ group, and the ﬁfth quintile formed the
01.
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As government healthcare agendas prioritize shifting trends in
population aging and the corresponding impact on healthcare
spending, there is an ever increasing need to ﬁll the knowledge
gap around AMI healthcare costs for the elderly along the contin-
uum of care. This study provided a baseline analysis of the direct
healthcare costs and cost drivers for AMI across a six-year care
continuum in Ontario, Canada that will be critical for informing
economic analysis and future decision making about integrated
care for AMI among the elderly. The novel costing approach was
also useful in identifying a number of new areas of inquiry related
to cost drivers along the continuum of care and their role in gener-
ating health spending.
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